Do Cancer Drugs Benefit Patients?

Do Cancer Drugs Benefit Patients

“High priced cancer drugs get rushed approvals despite poor trial methodology and little effect on the longevity of patients and drug reviewers do not look to the long-term survival of patients who take them”, according to a new study published in the British Medical Journal.

Researchers said “Patients and their doctors should demand that regulators require companies to provide clear evidence of clinical effectiveness of the drugs, resulting from rigorous methodology.” “Drug agencies like the Food and Drug Administration (FDA) and the European Medical Agency (EMA) don’t actually look at whether people live longer.” They reported that solid cancer drugs reviewed within the past 10 years by the EMA improved survival by 1 month.  “Similarily 71 drugs approved by the FDA from 2002 to 2014 for solid tumours have resulted in median gains in progression-free and overall survival of only 2.5 and 2.1 months, respectively.” He added that “Only 42 percent met the American Society of Clinical Oncology Cancer Research Committee’s criteria for meaningful results for patients”

 

Comments are closed.